Denmark· DK-28104050606

Arlevert

A cinnarizin, kombinationen product containing cinnarizin, dimenhydrinat, registered in Denmark by Hennig Arzneimittel AG. The same ATC class is registered in 9 of our 19 countries.

ATC N07CA52

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedArlevertATCN07CA52REGISTER NO.DK-28104050606PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Cinnarizin, kombinationen is registered in 9 of 19 countries.

Countries holding a registration under ATC N07CA52 (cinnarizin, kombinationen), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 6 of them publish a price we can compare per daily dose

Cinnarizin, kombinationen · ATC N07CA52

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cinnarizin, kombinationen costs, country by country.

Normalised to the WHO defined daily dose (90 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Cinnarizin, kombinationen · price per daily dose (90 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.98
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
CINNARIZIN, Dimenhydrinat
Manufacturer
Hennig Arzneimittel AG
Country
Denmark (DK)
ATC code
N07CA52
ATC class
Cinnarizin, Kombinationen
Defined daily dose
90 mg, O
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28104050606

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/68936620-5d82-4ed7-8e55-e3063e0c1326
GET /v1/drugs/68936620-5d82-4ed7-8e55-e3063e0c1326?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "tabletter",
  "source": "dkma",
  "strength": "20+40 mg",
  "auth_role": "CMS",
  "dk_drugid": "28104050606",
  "substance": "CINNARIZIN, Dimenhydrinat",
  "auth_procedure": "MRP",
  "in_medicinpriser": false,
  "registration_date_serial": "39218"
}

See everything about cinnarizin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.